Tarumi Y - Search Results

1

A case of ovarian carcinosarcoma with germline BRCA2 pathogenic variant.

Yoriki K, Izumi Y, Tarumi Y, Okimura H, Maeda E, Mori T. Yoriki K, et al. Among authors: tarumi y. J Obstet Gynaecol Res. 2024 Oct 29. doi: 10.1111/jog.16134. Online ahead of print. J Obstet Gynaecol Res. 2024. PMID: 39472984

2

Endometrioid adenocarcinoma arising from deep infiltrating endometriosis involving the bladder: A case report and review of the literature.

Tarumi Y, Mori T, Kusuki I, Ito F, Kitawaki J. Tarumi Y, et al. Gynecol Oncol Rep. 2015 Jul 15;13:68-70. doi: 10.1016/j.gore.2015.07.003. eCollection 2015 Aug. Gynecol Oncol Rep. 2015. PMID: 26425727 Free PMC article.

3

Long-term survival with bevacizumab in heavily pretreated and platinum-resistant mucinous ovarian cancer: A case report.

Tarumi Y, Mori T, Matsushima H, Kokabu T, Tsuchiya H, Kitawaki J. Tarumi Y, et al. J Obstet Gynaecol Res. 2018 Feb;44(2):347-351. doi: 10.1111/jog.13496. Epub 2017 Nov 9. J Obstet Gynaecol Res. 2018. PMID: 29121427

4

Equilin in conjugated equine estrogen increases monocyte-endothelial adhesion via NF-κB signaling.

Ito F, Mori T, Tarumi Y, Okimura H, Kataoka H, Tanaka Y, Koshiba A, Kitawaki J. Ito F, et al. Among authors: tarumi y. PLoS One. 2019 Jan 30;14(1):e0211462. doi: 10.1371/journal.pone.0211462. eCollection 2019. PLoS One. 2019. PMID: 30699196 Free PMC article.

5

Antitumor effect of XCT790, an ERRα inverse agonist, on ERα-negative endometrial cancer cells.

Kokabu T, Mori T, Matsushima H, Yoriki K, Kataoka H, Tarumi Y, Kitawaki J. Kokabu T, et al. Among authors: tarumi y. Cell Oncol (Dordr). 2019 Apr;42(2):223-235. doi: 10.1007/s13402-019-00423-5. Epub 2019 Jan 31. Cell Oncol (Dordr). 2019. PMID: 30706380

6

Yoriki K, Mori T, Kokabu T, Matsushima H, Umemura S, Tarumi Y, Kitawaki J. Yoriki K, et al. Among authors: tarumi y. Sci Rep. 2019 Apr 30;9(1):6697. doi: 10.1038/s41598-019-43261-z. Sci Rep. 2019. PMID: 31040369 Free PMC article.

7

Peroxisome proliferator-activated receptor-γ coactivator 1α-mediated pathway as a possible therapeutic target in endometriosis.

Kataoka H, Mori T, Okimura H, Matsushima H, Ito F, Koshiba A, Tanaka Y, Akiyama K, Maeda E, Sugahara T, Tarumi Y, Kusuki I, Khan KN, Kitawaki J. Kataoka H, et al. Among authors: tarumi y. Hum Reprod. 2019 Jun 4;34(6):1019-1029. doi: 10.1093/humrep/dez067. Hum Reprod. 2019. PMID: 31119261

8

Atherosclerosis-related biomarkers in women with endometriosis: The effects of dienogest and oral contraceptive therapy.

Maeda E, Koshiba A, Mori T, Ito F, Kataoka H, Okimura H, Sugahara T, Tarumi Y, Kusuki I, Khan KN, Kitawaki J. Maeda E, et al. Among authors: tarumi y. Eur J Obstet Gynecol Reprod Biol X. 2020 Apr 23;7:100108. doi: 10.1016/j.eurox.2020.100108. eCollection 2020 Jul. Eur J Obstet Gynecol Reprod Biol X. 2020. PMID: 32715291 Free PMC article.

9

Successful detection of rectal injury during laparoscopic surgery using a rectal probe in a patient with deep endometriosis.

Yoriki K, Kusuki I, Kawamata M, Tarumi Y, Mori T, Kitawaki J. Yoriki K, et al. Among authors: tarumi y. J Obstet Gynaecol Res. 2021 Jan;47(1):425-429. doi: 10.1111/jog.14535. Epub 2020 Oct 18. J Obstet Gynaecol Res. 2021. PMID: 33073414

10

Interleukin-9 produced by helper T cells stimulates interleukin-8 expression in endometriosis.

Tarumi Y, Mori T, Okimura H, Maeda E, Tanaka Y, Kataoka H, Ito F, Koshiba A, Kusuki I, Kitawaki J. Tarumi Y, et al. Am J Reprod Immunol. 2021 Sep;86(3):e13380. doi: 10.1111/aji.13380. Epub 2021 Jul 20. Am J Reprod Immunol. 2021. PMID: 33210782

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters